Cargando…
Impact of Portal Vein Resection (PVR) in Patients Who Underwent Curative Intended Pancreatic Head Resection
The oncological impact of portal vein resection (PVR) in pancreatic cancer surgery remains contradictory. Different variables might have an impact on the outcome. The aim of the present study is the retrospective assessment of the frequency of PVR, histological confirmation of tumor infiltration, an...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669675/ https://www.ncbi.nlm.nih.gov/pubmed/38002027 http://dx.doi.org/10.3390/biomedicines11113025 |
_version_ | 1785139752238841856 |
---|---|
author | Bernhardt, Markus Rühlmann, Felix Azizian, Azadeh Kölling, Max Alexander Beißbarth, Tim Grade, Marian König, Alexander Otto Ghadimi, Michael Gaedcke, Jochen |
author_facet | Bernhardt, Markus Rühlmann, Felix Azizian, Azadeh Kölling, Max Alexander Beißbarth, Tim Grade, Marian König, Alexander Otto Ghadimi, Michael Gaedcke, Jochen |
author_sort | Bernhardt, Markus |
collection | PubMed |
description | The oncological impact of portal vein resection (PVR) in pancreatic cancer surgery remains contradictory. Different variables might have an impact on the outcome. The aim of the present study is the retrospective assessment of the frequency of PVR, histological confirmation of tumor infiltration, and comparison of oncological outcomes in PVR patients. We retrieved n = 90 patients from a prospectively collected data bank who underwent pancreas surgery between 2012 and 2019 at the University Medical Centre Göttingen (Germany) and showed a histologically confirmed pancreatic ductal adenocarcinoma (PDAC). While 50 patients (55.6%) underwent pancreatic resection combined with PVR, 40 patients (44.4%) received standard pancreatic surgery. Patients with distal pancreatectomy or a tumor other than PDAC were excluded. PVR was performed either as local excision or circular resection of the portal vein. Clinical/patient data and follow-ups were retrieved. The median follow-up period was 20.5 months. Regarding the oncological outcome, a statistically poorer CSS (p = 0.04) was observed in PVR patients. There was no difference (p = 0.18) in patients’ outcomes between tangential and complete PVR, while n = 21 (42% of PVR patients) showed portal vein infiltration. The correlation between performed PVR and resection status was statistically significant: 48.6% of PVR patients achieved R0 resections compared to 75% in non-PVR patients (p = 0.03). Patients who underwent PDAC surgery with PVR show a significantly poorer outcome regardless of PVR type. Tumor size and R-status remain two important variables significantly associated with outcome. Since there is a lack of standardization for the indication of PVR, it remains unknown if the need for resection of vein structures during pancreatic resection represents the biological aggressiveness of the tumor or is biased by the experience of the surgeon. |
format | Online Article Text |
id | pubmed-10669675 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106696752023-11-11 Impact of Portal Vein Resection (PVR) in Patients Who Underwent Curative Intended Pancreatic Head Resection Bernhardt, Markus Rühlmann, Felix Azizian, Azadeh Kölling, Max Alexander Beißbarth, Tim Grade, Marian König, Alexander Otto Ghadimi, Michael Gaedcke, Jochen Biomedicines Article The oncological impact of portal vein resection (PVR) in pancreatic cancer surgery remains contradictory. Different variables might have an impact on the outcome. The aim of the present study is the retrospective assessment of the frequency of PVR, histological confirmation of tumor infiltration, and comparison of oncological outcomes in PVR patients. We retrieved n = 90 patients from a prospectively collected data bank who underwent pancreas surgery between 2012 and 2019 at the University Medical Centre Göttingen (Germany) and showed a histologically confirmed pancreatic ductal adenocarcinoma (PDAC). While 50 patients (55.6%) underwent pancreatic resection combined with PVR, 40 patients (44.4%) received standard pancreatic surgery. Patients with distal pancreatectomy or a tumor other than PDAC were excluded. PVR was performed either as local excision or circular resection of the portal vein. Clinical/patient data and follow-ups were retrieved. The median follow-up period was 20.5 months. Regarding the oncological outcome, a statistically poorer CSS (p = 0.04) was observed in PVR patients. There was no difference (p = 0.18) in patients’ outcomes between tangential and complete PVR, while n = 21 (42% of PVR patients) showed portal vein infiltration. The correlation between performed PVR and resection status was statistically significant: 48.6% of PVR patients achieved R0 resections compared to 75% in non-PVR patients (p = 0.03). Patients who underwent PDAC surgery with PVR show a significantly poorer outcome regardless of PVR type. Tumor size and R-status remain two important variables significantly associated with outcome. Since there is a lack of standardization for the indication of PVR, it remains unknown if the need for resection of vein structures during pancreatic resection represents the biological aggressiveness of the tumor or is biased by the experience of the surgeon. MDPI 2023-11-11 /pmc/articles/PMC10669675/ /pubmed/38002027 http://dx.doi.org/10.3390/biomedicines11113025 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bernhardt, Markus Rühlmann, Felix Azizian, Azadeh Kölling, Max Alexander Beißbarth, Tim Grade, Marian König, Alexander Otto Ghadimi, Michael Gaedcke, Jochen Impact of Portal Vein Resection (PVR) in Patients Who Underwent Curative Intended Pancreatic Head Resection |
title | Impact of Portal Vein Resection (PVR) in Patients Who Underwent Curative Intended Pancreatic Head Resection |
title_full | Impact of Portal Vein Resection (PVR) in Patients Who Underwent Curative Intended Pancreatic Head Resection |
title_fullStr | Impact of Portal Vein Resection (PVR) in Patients Who Underwent Curative Intended Pancreatic Head Resection |
title_full_unstemmed | Impact of Portal Vein Resection (PVR) in Patients Who Underwent Curative Intended Pancreatic Head Resection |
title_short | Impact of Portal Vein Resection (PVR) in Patients Who Underwent Curative Intended Pancreatic Head Resection |
title_sort | impact of portal vein resection (pvr) in patients who underwent curative intended pancreatic head resection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669675/ https://www.ncbi.nlm.nih.gov/pubmed/38002027 http://dx.doi.org/10.3390/biomedicines11113025 |
work_keys_str_mv | AT bernhardtmarkus impactofportalveinresectionpvrinpatientswhounderwentcurativeintendedpancreaticheadresection AT ruhlmannfelix impactofportalveinresectionpvrinpatientswhounderwentcurativeintendedpancreaticheadresection AT azizianazadeh impactofportalveinresectionpvrinpatientswhounderwentcurativeintendedpancreaticheadresection AT kollingmaxalexander impactofportalveinresectionpvrinpatientswhounderwentcurativeintendedpancreaticheadresection AT beißbarthtim impactofportalveinresectionpvrinpatientswhounderwentcurativeintendedpancreaticheadresection AT grademarian impactofportalveinresectionpvrinpatientswhounderwentcurativeintendedpancreaticheadresection AT konigalexanderotto impactofportalveinresectionpvrinpatientswhounderwentcurativeintendedpancreaticheadresection AT ghadimimichael impactofportalveinresectionpvrinpatientswhounderwentcurativeintendedpancreaticheadresection AT gaedckejochen impactofportalveinresectionpvrinpatientswhounderwentcurativeintendedpancreaticheadresection |